This page is part of the Healthcare Associated Infection Implementation Guide (v1.1.0: STU 2 Ballot 1) based on FHIR R3. The current version which supercedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions 
XML Format: ValueSet-2.16.840.1.113883.13.13
Raw xml
<ValueSet xmlns="http://hl7.org/fhir"> <id value="2.16.840.1.113883.13.13"/> <meta> <versionId value="1"/> <lastUpdated value="2019-03-06T08:59:54.000+11:00"/> </meta> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><h2>NHSNDrugSusceptibilityFindingCode</h2><div><p>Codes representing a drug susceptibility finding.</p> </div><p>This value set includes codes from the following code systems:</p><ul><li>Include these codes as defined in <a href="http://hl7.org/fhir/STU3/v3/ObservationInterpretation/cs.html"><code>http://hl7.org/fhir/v3/ObservationInterpretation</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="http://hl7.org/fhir/STU3/v3/ObservationInterpretation/cs.html#v3-ObservationInterpretation-I">I</a></td><td>Intermediate</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/> [Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.]<br/> [Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.]<br/> [Note 3: This class also indicates a "buffer zone," to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.]<br/> [Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]</td></tr><tr><td><a href="http://hl7.org/fhir/STU3/v3/ObservationInterpretation/cs.html#v3-ObservationInterpretation-R">R</a></td><td>Resistant</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/> [Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.]<br/> [Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]</td></tr><tr><td><a href="http://hl7.org/fhir/STU3/v3/ObservationInterpretation/cs.html#v3-ObservationInterpretation-S">S</a></td><td>Susceptible</td><td>Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2<br/> [Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.]<br/> [Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]</td></tr><tr><td><a href="http://hl7.org/fhir/STU3/v3/ObservationInterpretation/cs.html#v3-ObservationInterpretation-NS">NS</a></td><td>Non-Susceptible</td><td>A category used for isolates for which only a susceptible interpretive criterion has been designated because of the absence or rare occurrence of resistant strains. Isolates that have MICs above or zone diameters below the value indicated for the susceptible breakpoint should be reported as non-susceptible.<br/> NOTE 1: An isolate that is interpreted as non-susceptible does not necessarily mean that the isolate has a resistance mechanism. It is possible that isolates with MICs above the susceptible breakpoint that lack resistance mechanisms may be encountered within the wild-type distribution subsequent to the time the susceptible-only breakpoint is set. <br/> NOTE 2: For strains yielding results in the "nonsusceptible" category, organism identification and antimicrobial susceptibility test results should be confirmed.<br/> Synonym: decreased susceptibility.</td></tr><tr><td><a href="http://hl7.org/fhir/STU3/v3/ObservationInterpretation/cs.html#v3-ObservationInterpretation-S-DD">S-DD</a></td><td>Susceptible-dose dependant</td><td/></tr></table></li></ul></div> </text> <url value="http://hl7.org/fhir/us/hai/ValueSet/2.16.840.1.113883.13.13"/> <version value="1.1.0"/> <name value="NHSNDrugSusceptibilityFindingCode"/> <status value="active"/> <date value="2019-03-27T07:21:32+11:00"/> <description value="Codes representing a drug susceptibility finding."/> <compose> <include> <system value="http://hl7.org/fhir/v3/ObservationInterpretation"/> <concept> <code value="I"/> <display value="Intermediate"/> </concept> <concept> <code value="R"/> <display value="Resistant"/> </concept> <concept> <code value="S"/> <display value="Susceptible"/> </concept> <concept> <code value="NS"/> <display value="Non-Susceptible"/> </concept> <concept> <code value="S-DD"/> <display value="Susceptible-dose dependant"/> </concept> </include> </compose> </ValueSet>
